Transcutaneous PO2 and laser Doppler flowmetry in patients with arterial occlusive disease receiving intraarterial infusions of PGE1 or nucleotide phosphates.
D000328:Adult; D000368:Aged; D000527:Alprostadil / Q000008:administration & dosage / Q000627:therapeutic use*; D001157:Arterial Occlusive Diseases / Q000188:drug therapy / Q000503:physiopathology*; D001775:Blood Circulation; D005260:Female; D006801:Humans; D007261:Infusions, Intra-Arterial; D007834:Lasers; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D010100:Oxygen / Q000032:analysis; D010313:Partial Pressure; D012212:Rheology; D012265:Ribonucleotides / Q000008:administration & dosage / Q000627:therapeutic use*; D012867:Skin / Q000187:drug effects / Q000503:physiopathology*
D012265:Ribonucleotides; D000527:Alprostadil; D010100:Oxygen